WallStreetZenWallStreetZen

NASDAQ: ARCT
Arcturus Therapeutics Holdings Inc Earnings & Revenue

Buy ARCT
OverviewForecastEarnings
DividendOwnership

ARCT past revenue growth

How has ARCT's revenue growth performed historically?
Company
71.57%
Industry
1,257.1%
Market
54.3%
ARCT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARCT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARCT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ARCT earnings and revenue history

Current Revenue
$15.5M
Current Earnings
-$198.5M
Current Profit Margin
-1,282.6%

ARCT Return on Equity

Current Company
-81.2%
Current Industry
6.8%
Current Market
38.4%
ARCT's Return on Equity (-81.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ARCT Return on Assets

Current Company
-49.1%
Current Industry
5.1%
ARCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ARCT Return on Capital Employed

Current Company
-83.67%
Current Industry
-16.5%
ARCT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARCT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ARCT$15.48M-$195.26M-$198.50M-50.32%N/A
COGT$0.00-$90.98M-$91.18M-100.00%N/A
EWTX$0.00-$50.34M-$50.66MN/AN/A
ABUS$21.46M-$66.89M-$84.56M+80.40%N/A
CNTA$0.00N/A-$196.88MN/AN/A
View Top Biotech Stocks

ARCT earnings dates

Next earnings date
Aug 8, 2022

Arcturus Therapeutics Holdings Earnings & Revenue FAQ

What were ARCT's earnings last quarter?

On Invalid Date, Arcturus Therapeutics Holdings (NASDAQ: ARCT) reported Q1 2022 earnings per share (EPS) of -$1.94, up 9.77% year over year. Total Arcturus Therapeutics Holdings earnings for the quarter were -$51.17 million. In the same quarter last year, Arcturus Therapeutics Holdings's earnings per share (EPS) was -$2.15.

What was ARCT's earnings growth in the past year?

As of Q2 2022, Arcturus Therapeutics Holdings's earnings has grown null year over year. Arcturus Therapeutics Holdings's earnings in the past year totalled -$198.50 million.

What is ARCT's earnings date?

Arcturus Therapeutics Holdings's earnings date is Invalid Date. Add ARCT to your watchlist to be reminded of ARCT's next earnings announcement.

What was ARCT's revenue last quarter?

On Invalid Date, Arcturus Therapeutics Holdings (NASDAQ: ARCT) reported Q1 2022 revenue of $5.24 million up 146.54% year over year. In the same quarter last year, Arcturus Therapeutics Holdings's revenue was $2.13 million.

What was ARCT's revenue growth in the past year?

As of Q2 2022, Arcturus Therapeutics Holdings's revenue has grown 71.57% year over year. This is 1,185.53 percentage points lower than the US Biotechnology industry revenue growth rate of 1,257.1%. Arcturus Therapeutics Holdings's revenue in the past year totalled $15.48 million.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.